Redeye: Bredband2 - Continued margin focus
Redeye makes minor forecast adjustments following Bredband2’s Q4 2022 report, where the sales were largely in line, while the EBITDA and EBIT margin came in slightly below. Accordingly, the forecast adjustments give rise to a new fair value range.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/